Skip to main content

What the FDA labels say about taking them together

Diazepam and raloxifene

Raloxifene's FDA label of April 14, 2026 names diazepam in its drug interactions section; the diazepam labels PlainMeds reads (4) do not name raloxifene.

Check it at the source: the diazepam FDA label on DailyMed (effective August 11, 2026, Waylis Therapuetics LLC); the raloxifene FDA label on DailyMed (effective April 14, 2026, Amneal Pharmaceuticals LLC).

What does the diazepam label say about raloxifene?

Diazepam's label (effective August 11, 2026) and its 3 other brand-application labels do not name raloxifene in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Valium), Waylis Therapuetics LLC, effective August 11, 2026 (SPL set 260e2041-2bb3-482f-850e-b5d47a7bdbe6), via openFDA; the full label on DailyMed

What does the raloxifene label say about diazepam?

Raloxifene label, drug interactions

Raloxifene hydrochloride should be used with caution with certain other highly protein-bound drugs such as diazepam, diazoxide, and lidocaine.

Source: FDA drug label (Evista, NDA020815), Eli Lilly and Company, effective February 11, 2026 (SPL set fcaaa6dc-74e8-4fb8-800c-5574bf0f8de9), via openFDA

Source: FDA drug label (Raloxifene Hydrochloride), Amneal Pharmaceuticals LLC, effective April 14, 2026 (SPL set 3798c70b-a4b0-4811-9788-e4c9cff47ebe), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

45Diazepam generic labelers
17Raloxifene generic labelers
DiazepamRaloxifene
Labeled forAnxiety, Muscle spasms and spasticityOsteoporosis, Breast cancer
Boxed warningYesYes
Pharmacy cost (NADAC)$0.0283 per tablet 10 mg tablet$0.223 per tablet 60 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?